SKIN
Innovator:
Inv. Maria Beihaghi
Owner of the innovation:
Medicinal products based on exosomes derived from plants, humans, algae, and medicinal mushrooms to treat the skin diseases
Acknowledgment: Congratulations on being one of the pioneer innovators who have obtained the IFIA Innovation Standard certificate (IIS).
Following your inquiry for an IIS certification, the jury board evaluated your application according to the criteria. And after the assessment and examinations, your innovation was granted with IFIA Innovation Standard Grade A.
IFIA hopes that by having this certification, you will take an essential step in the commercialization of your innovation. Also, by entering international markets, you can contribute to the realization of the global slogan: Generating wealth through innovative knowledge.
The Summary of Innovation:
The invention of medicinal products based on plant exosomes, algae, and medicinal mushrooms to treat skin diseases are beneficial compounds, which have been selected from the extracts and essences of the intended plant families in accordance with the disease target. They are made with purified exosomes from the above-listed plants, spirulina algae, and shiitake mushrooms. Plant-derived exosomes have a structure similar to exosomes isolated from mammals and act as extracellular messengers in intercellular communication. Moreover, these vesicles are capable of transferring mRNAs, microRNAs (miRNAs), bioactive lipids, and proteins to human and animal cells.
Key Features:
• Multiple plants with special medicinal properties and without allergic effects are employed in Iran for the treatment of many skin diseases with easy access.
• Plant-derived exosomes with high absorption and low toxicity, edible shiitake mushroom, and spirulina algae, are used as delivery systems and drug carriers to treat diseases.
• Human blood serum is exploited exclusively for the extraction of exosomes and the application of exosomes in medicinal and cosmetic compounds.
• Because of the excellent anti-melanogenesis and anti-aging properties of plant-derived exosomes, cosmetic products are generated for skin rejuvenation.
• Plant exosomes are utilized to decline melanin and free radicals, and thus lighten and rejuvenate the skin.
Why is this innovation eligible to receive the IIS certification?
This invention is an appropriate alternative to cosmetic creams for treating hyperpigmentation, skin treatments for eczema, blemishes and melasma, and skin sagging & aging, which will be a critical step towards upgrading the level of the health of communities. These Medicinal Products based on Exosomes Derived from Plants, Humans, Algae, and Medicinal Mushrooms to Treat the Skin Diseases and It is essential to balance between synthesis and breakdown of collagen for maintaining skin rejuvenation and regeneration .These restorative products have been used according to the skin problems of each person in order to reduce melanin and free radicals and as a result lighten and rejuvenate the skin and repair the damaged skin tissue. Human blood serum exosomes are also used as delivery systems and suitable drug carriers for the treatment of many skin diseases. The above-mentioned engineered products cause the re-proliferation of skin cells and collagen regeneration, and also prevent wound hyperplasia. Also Reduce production cost It is used to heal wounds, treat hyperpigmentation, eczema, spots and melasma, sagging and aging skin, etc.
Inventor
